http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID222909_PMID11020298

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103355302_AID222909_PMID11020298_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103354782_AID222909_PMID11020298_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103279702_AID222909_PMID11020298_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103355496_AID222909_PMID11020298_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103355261_AID222909_PMID11020298_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103279669_AID222909_PMID11020298_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103354781_AID222909_PMID11020298_VALUE3
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID216
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title In vitro inhibitory activity for human renal cancer cell line CAK-1 was determined.
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103354782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103355302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103355261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103355496
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103279702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103354781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103279669
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID222909

Total number of triples: 19.